Can some early revision total hip arthroplasties be avoided?


Journal

The bone & joint journal
ISSN: 2049-4408
Titre abrégé: Bone Joint J
Pays: England
ID NLM: 101599229

Informations de publication

Date de publication:
06 2019
Historique:
entrez: 1 6 2019
pubmed: 31 5 2019
medline: 14 6 2019
Statut: ppublish

Résumé

Studying the indications for revision total hip arthroplasty (THA) may enable surgeons to change their practice during the initial procedure, thereby reducing the need for revision surgery. The aim of this study was to identify and describe the potentially avoidable indications for revision THA within five years of the initial procedure. A retrospective review of 117 patients (73 women, 44 men; mean age 61.5 years (27 to 88)) who met the inclusion criteria was conducted. Three adult reconstruction surgeons independently reviewed the radiographs and medical records, and they classified the revision THAs into two categories: potentially avoidable and unavoidable. Baseline demographics, perioperative details, and quality outcomes up to the last follow-up were recorded. A total of 60 revision THAs (51.3%) were deemed potentially avoidable and 57 (48.7%) were deemed unavoidable. The following were identified as avoidable factors: suboptimal positioning of the acetabular component (29; 48%), intraoperative fracture or a fracture missed on an intraoperative radiograph (20; 33%), early (less than two weeks) aseptic loosening (seven; 11.7%), and symptomatic leg length discrepancy of > 1 cm (four; 6.7%). A surprisingly large proportion of acute revision THAs are potentially avoidable. Surgeons must carefully evaluate the indications for revision THAs in their practice and identify new methods to address these issues. Cite this article:

Identifiants

pubmed: 31146556
doi: 10.1302/0301-620X.101B6.BJJ-2018-1448.R1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-103

Auteurs

D Novikov (D)

Department of Orthopaedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York, USA.
Department of Orthopaedic Surgery, Boston University Medical Center, Boston, Massachusetts, USA.

J J Mercuri (JJ)

Department of Orthopaedic Surgery, Geisinger Musculoskeletal Institute, Geisinger Health System, Scranton, Philadelphia, USA.

Ran Schwarzkopf (R)

Department of Orthopaedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York, USA.

W J Long (WJ)

Department of Orthopaedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York, USA.

J A Bosco Iii (JA)

Department of Orthopaedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York, USA.

J M Vigdorchik (JM)

Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH